ISPOR Recognized by MarCom Awards for Its Annual Report and Rebranding of Value in Health

Published Dec 3, 2019

Society Wins 3 Platinum Awards and 1 Gold Award

Lawrenceville, NJ, USA—December 3, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR), announced that it has won a number of MarCom Awards recognizing the rebranding of its high-impact journal Value in Health and for its 2018 Annual Report.

The MarCom Awards honor excellence in marketing and communication. Since its inception in 2004, the MarCom Awards program has evolved into one of the largest, most-respected creative competitions in the world. Each year approximately 6000 entries are submitted to the MarCom Awards from around the world.

Value in Health Redesign/Anniversary Issue

Value in HealthAs part of ISPOR’s global brand refresh, the Society launched a redesign of its flagship journal—the high-impact, highly ranked Value in Health. The MarCom Awards recognized this rebrand that launched with its 20th anniversary issue with a Gold Award in the Print Media | Design/Print | Other/Journal category. The new journal design reflects a more contemporary look that features a new cover, new page layout, and the use of color to improve overall readability. To mark this important 20th anniversary milestone, the journal’s editors commissioned articles that dealt with topics that have been widely discussed in the journal over the past 20 years, but for which there is an exciting future agenda in the field of HEOR.

Annual Report

ISPOR 2018 Annual Report CoverISPOR published a 2018 Annual Report this year; its first annual report in many years. The MarCom Awards recognized this publication with 3 Platinum Awards. The Platinum Award categories won were (1) Print Media | Annual Report | Association, (2) Print Media | Annual Report | Nonprofit, and (30 Print Media | Annual Report | Design.

ISPOR’s creative partner for the initiatives recognized was Taft Communications.


ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: | LinkedIn: | Twitter: (@ISPORorg) | YouTube: | Facebook: | Instagram:

Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2017 impact factor score is 5.494. Value in Health is ranked 3rd among 94 journals in healthcare sciences and services, 3rd among 79 journals in health policy and services, and 6th among 353 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: | Twitter: (@ISPORjournals)

MarCom Awards honors excellence in marketing and communication while recognizing the creativity, hard work and generosity of industry professionals. Since its inception in 2004, MarCom has evolved into one of the largest, most-respected creative competitions in the world. Each year about 6,000 print and digital entries are submitted from dozens of countries. MarCom is administered by the Association of Marketing and Communication Professionals (AMCP)

Related Stories

Incorporating Patients’ Perspectives in the Medical Device Regulatory Process

Apr 8, 2020

Value in Health announced the publication of an article highlighting US Food and Drug Administration (FDA) guidance and lessons learned regarding the use of patient preference information for FDA decision making about medical devices

ISPOR Value of Information Task Force Publishes Two New Good Practices Reports

Mar 31, 2020

Value in Health, the official journal of ISPOR, announced today the publication of 2 Good Practices Reports that together describe the findings of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.

Formulary Exclusions and Prior Authorization Requirements Continue to Limit Patient Access to PCSK9is

Mar 4, 2020

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that insurer approval rates for PCSK9i prescriptions remain low.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now